Final Effectiveness and Safety Results of NABUCCO – Real-World Data from a Non-Interventional, Prospective, Multi-Center Study in 697 Patients with Metastatic Breast Cancer Treated with Nab-Paclitaxel.

Marschner, N., C. Salat, U. Söling, R. Hansen, S. Grebhardt, J. Harde, A. Nusch, and K. Potthoff.

Epub ahead of print: Clinical Breast Cancer 0, no. 0 (15 July 2018). https://doi.org/10.1016/j.clbc.2018.07.010.

Abstract